Delivery Order SPE2DB24D2018-SPE2DB24FWTE1

Award Date 6/21/24
Potential Completion Date 7/15/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The $7,905.56 order is for the delivery of OFEV 150 MG capsules, a specialty pharmaceutical product, with a performance period through April 15, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $7,905.56 order is for the provision of OFEV 150 MG capsules. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the...
This is a $7,905.56 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of OFEV 150 MG capsules, a pharmaceutical product. The ultimate completion date for this award is July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical commodities,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of OFEV 150 mg capsules. The contract, valued at $7,905.56, is a firm-fixed price delivery order without any set-aside requirements, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, is fulfilling this order as part of its Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
The Defense Logistics Agency (DLA) has awarded a $7,905.56 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division to supply OFEV 150 MG CAPSULE 60S. This contract does not have a set-aside designation and has an ultimate completion date of September 25, 2024. AmerisourceBergen, a large pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and Department of Justice to provide a range of critical medical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The $31,663.36 contract provides OFEV 100 MG capsules to support military treatment programs and facilities. Amerisourcebergen Drug Corporation holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary...
This is a $15,811.12 federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of OFEV 150 MG capsules and has a period of performance through October 4, 2024. The contract is a firm-fixed price arrangement and is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OFEV 150 MG CAPSULE 60S. The firm-fixed-price contract is valued at $15,811.12 and has an ultimate completion date of October 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $7,905.56 firm fixed price contract is for the supply of OFEV 150 MG capsules. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by DLA and other agencies to provide a wide range of pharmaceutical and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of OFEV 150 MG capsules. The contract has a firm-fixed price of $7,905.56 and an ultimate completion date of August 8, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with various federal agencies, including the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, to provide...
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB24FWTE1
    Delivery Order

This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $7,905.56 contract is for the delivery of OFEV 150 MG capsules and does not have a set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distribution companies, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/20/24, 9:32 AM